Literature DB >> 29337683

How protein coronas determine the fate of engineered nanoparticles in biological environment.

Ivona Capjak1, Sandra Šupraha Goreta2, Darija Domazet Jurašin3, Ivana Vinković Vrček4.   

Abstract

Nanomedicine is a booming medical field that utilises nanoparticles (NPs) for the development of medicines, medical devices, and diagnostic tools. The behaviour of NPs in vivo may be quite complex due to their interactions with biological molecules. These interactions in biological fluids result in NPs being enveloped by dynamic protein coronas, which serve as an interface between NPs and their environment (blood, cell, tissue). How will the corona interact with this environment will depend on the biological, chemical, and physical properties of NPs, the properties of the proteins that make the corona, as well as the biological environment. This review summarises the main characteristics of protein corona and describes its dynamic nature. It also presents the most common analytical methods to study the corona, including examples of protein corona composition for the most common NPs used in biomedicine. This knowledge is necessary to design NPs that will create a corona with a desired efficiency and safety in clinical use.

Entities:  

Keywords:  hard corona; nano-bio interface; nanomedicine; soft corona

Mesh:

Substances:

Year:  2017        PMID: 29337683     DOI: 10.1515/aiht-2017-68-3054

Source DB:  PubMed          Journal:  Arh Hig Rada Toksikol        ISSN: 0004-1254            Impact factor:   1.948


  8 in total

1.  Toxicological Aspects of Iron Oxide Nanoparticles.

Authors:  Natalia Fernández-Bertólez; Carla Costa; Fátima Brandão; João Paulo Teixeira; Eduardo Pásaro; Vanessa Valdiglesias; Blanca Laffon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association.

Authors:  Hossein Mohammad-Beigi; Yuya Hayashi; Christina Moeslund Zeuthen; Hoda Eskandari; Carsten Scavenius; Kristian Juul-Madsen; Thomas Vorup-Jensen; Jan J Enghild; Duncan S Sutherland
Journal:  Nat Commun       Date:  2020-09-10       Impact factor: 14.919

3.  Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study.

Authors:  Subhra Mandal; Shawnalyn W Sunagawa; Pavan Kumar Prathipati; Michael Belshan; Annemarie Shibata; Christopher J Destache
Journal:  Nanomaterials (Basel)       Date:  2022-06-06       Impact factor: 5.719

Review 4.  Understanding cellular interactions with nanomaterials: towards a rational design of medical nanodevices.

Authors:  Francisca Villanueva-Flores; Andrés Castro-Lugo; Octavio T Ramírez; Laura A Palomares
Journal:  Nanotechnology       Date:  2019-11-26       Impact factor: 3.874

5.  Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro.

Authors:  Dhireshan Singh; Moganavelli Singh
Journal:  Pharmaceutics       Date:  2021-02-24       Impact factor: 6.321

6.  Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models.

Authors:  Leonie Aengenheister; Dörthe Dietrich; Amin Sadeghpour; Pius Manser; Liliane Diener; Adrian Wichser; Uwe Karst; Peter Wick; Tina Buerki-Thurnherr
Journal:  J Nanobiotechnology       Date:  2018-10-11       Impact factor: 10.435

Review 7.  COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles?

Authors:  Dina A Mosselhy; Jenni Virtanen; Ravi Kant; Wei He; Mady Elbahri; Tarja Sironen
Journal:  Nanomaterials (Basel)       Date:  2021-03-19       Impact factor: 5.076

8.  Fate and transformation of silver nanoparticles in different biological conditions.

Authors:  Barbara Pem; Marija Ćurlin; Darija Domazet Jurašin; Valerije Vrček; Rinea Barbir; Vedran Micek; Raluca M Fratila; Jesus M de la Fuente; Ivana Vinković Vrček
Journal:  Beilstein J Nanotechnol       Date:  2021-07-07       Impact factor: 3.649

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.